======= AEBP1 ======= == Gene Information == * **Official Symbol**: AEBP1 * **Official Name**: AE binding protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=165|165]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IUX7|Q8IUX7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AEBP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AEBP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602981|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May positively regulate MAP-kinase activity in adipocytes, leading to enhanced adipocyte proliferation and reduced adipocyte differentiation. May also positively regulate NF-kappa-B activity in macrophages by promoting the phosphorylation and subsequent degradation of I-kappa-B-alpha (NFKBIA), leading to enhanced macrophage inflammatory responsiveness. Can act as a transcriptional repressor. {ECO:0000250}. |Peptidase M14| |F5 F8 type C| |regulation of collagen fibril organization| |metallocarboxypeptidase activity| |regulation of extracellular matrix organization| |collagen binding| |extracellular matrix structural constituent| |protein processing| |calmodulin binding| |protein maturation| |transcription corepressor activity| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |RNA polymerase II regulatory region sequence-specific DNA binding| |regulation of supramolecular fiber organization| |collagen-containing extracellular matrix| |peptide metabolic process| |cellular amide metabolic process| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |extracellular space| |negative regulation of gene expression| |extracellular region| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.73| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.71| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.74| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.82| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.539| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4265 * **Expression level (log2 read counts)**: 10.82 {{:chemogenomics:nalm6 dist.png?nolink |}}